Diacordin Retard 120mg 30 tablets — Made in Czech — Free Delivery

Indications.

Mild to moderate arterial hypertension and angina pectoris.

Contraindications.

• Sick sinus syndrome, AV (AV) block II or III degree in patients without a functioning pacemaker.
• Severe bradycardia (below 50 bpm). Left ventricular failure with congestive lungs. Breastfeeding.
• Simultaneous use of dantrolene infusion (see Section "Interaction with other medicinal products and other types of interactions").
• Hypersensitivity to diltiazem or to excipients that are part of the drug.
• Use in combination with ivabradine (see Section "Interaction with other medicinal products and other forms of interaction").

Compound

active ingredient: diltiazem;

1 tablet contains diltiazem hydrochloride 90 mg

excipients: lactose 200, mountain wax, methylated silicon dioxide, magnesium stearate, polysorbate 80, emulsion of simethicone SE4, macrogol 6000, hypromellose 2910/15, yellow iron oxide (E172), talc.

Method of application and dose.

Diacordin® 90 retard tablets should be swallowed whole with a small amount of water, without breaking or chewing the tablet.

Patients should be advised that the tablet shell may pass through the gastrointestinal tract unchanged.

There are a number of formulations available, allowing you to adjust the dosage according to the individual needs of the patient. If necessary, careful dose titration should be taken into account, since the individual response to therapy of different patients may vary. When switching from one type of drug to another, dose adjustment may be required until a satisfactory response to therapy is achieved. To ensure sustained response to therapy after it has been achieved, especially with sustained release dosage forms, the 90 mg and 120 mg formulations should continue to be branded.

adults

Angina pectoris and arterial hypertension:

The initial dose is one tablet (90 mg or 120 mg) administered twice a day. Patient responses to therapy may vary, and dose requirements may differ significantly between individual patients. In some patients with angina pectoris, the use of high doses of the drug up to 480 mg per day has proven beneficial, especially in unstable angina. Doses of 360 mg per day may be required to ensure adequate control of blood pressure in patients with arterial hypertension.

Elderly patients and patients with impaired liver or kidney function

The heart rate should be monitored in these patients, and if it falls below 50 beats per minute, the dose should be increased.

angina:

The recommended initial dose of the drug is 1 tablet 60 mg 2 times a day. This dose may be increased to one tablet of the drug 90 mg or 120 mg in the application 2 times a day.

Arterial hypertension:

The initial dose should be one tablet of the drug 120 mg per day. It may be necessary to adjust the dose to one tablet of the drug 90 mg or 120 mg in the application 2 times a day.

Children.

The safety and efficacy of diltiazem in children have not been established, therefore, the use of the drug in children is not recommended.